Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
25.38 USD | +0.73% | -4.16% | -9.70% |
Apr. 01 | Doximity Business Under Pressure as Underlying Sales Falling, Jehoshaphat Research Says | MT |
Mar. 15 | JPMorgan Adjusts Price Target on Doximity to $25 From $22, Maintains Underweight Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-9.70% | 4.7B | |
+3.68% | 357B | |
+26.66% | 266B | |
+16.83% | 150B | |
+19.16% | 101B | |
+6.54% | 75.39B | |
+56.75% | 58.22B | |
+32.82% | 52.88B | |
-1.90% | 34.9B | |
+2.35% | 29.13B |
- Stock Market
- Equities
- DOCS Stock
- News Doximity, Inc.
- Raymond James Adjusts Doximity's Price Target to $80 From $62, Keeps Outperform Rating